Centene Corporation provided earnings guidance for the year 2018. For the full year 2018, the company expects adjusted EBITDA to be in the $2.3 billion to $2.5 billion range. Additionally, adjusted EBITDA represents approximately 4% of total revenue, at the midpoint in 2018. Operating cash flow is expected to be in the range of 1.5 to 2x net earnings on a long-term basis. The company has revised guidance for 2 items: first, to increase total revenue guidance range of $59.2 billion to $60 billion to reflect additional pass-through payments the company received in May; and second, to increase the shares outstanding to 198.7 million to 199.7 million as a result of the upsized equity offering completed in May. The company continues to expect adjusted diluted earnings per share of $6.75 to $7.15. This includes the Fidelis acquisition, which the company expects to close on July 1, 2018, and does not include any potential adjustments associated with the California Medicaid expansion items that previously discussed.